129 related articles for article (PubMed ID: 22547691)
21. Gender differences in device therapy for malignant ventricular arrhythmias.
Horton HL; Marinchak RA; Rials SJ; Kowey PR
Arch Intern Med; 1995 Nov; 155(21):2342-5. PubMed ID: 7487260
[TBL] [Abstract][Full Text] [Related]
22. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.
Moss AJ; Hall WJ; Cannom DS; Daubert JP; Higgins SL; Klein H; Levine JH; Saksena S; Waldo AL; Wilber D; Brown MW; Heo M
N Engl J Med; 1996 Dec; 335(26):1933-40. PubMed ID: 8960472
[TBL] [Abstract][Full Text] [Related]
23. Coronary vasospasm and aborted sudden death treated with an implantable defibrillator and stenting.
Fiocca L; Di Biasi M; Bruno N; Ciuffreda M; Zumbo F; Mangiameli D; Montenero AS
Ital Heart J; 2002 Apr; 3(4):270-3. PubMed ID: 12025377
[TBL] [Abstract][Full Text] [Related]
24. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of ventricular arrhythmias].
Bytesník J
Vnitr Lek; 2003 Sep; 49(9):754-62. PubMed ID: 14584428
[TBL] [Abstract][Full Text] [Related]
26. Antiarrhythmic therapy in heart failure.
Eckardt L; Haverkamp W; Breithardt G
Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
[TBL] [Abstract][Full Text] [Related]
27. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention.
Das MK; Zipes DP
J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177
[TBL] [Abstract][Full Text] [Related]
28. Statins, ventricular arrhythmias and heart rate variability in patients with implantable cardioverter defibrillators and coronary heart disease.
Riahi S; Schmidt EB; Christensen JH; Heath F; Pedersen AK; Nielsen JC; Mølgaard H; Toft E
Cardiology; 2005; 104(4):210-4. PubMed ID: 16155396
[TBL] [Abstract][Full Text] [Related]
29. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
Bardy GH; Yee R; Jung W
J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
[TBL] [Abstract][Full Text] [Related]
30. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
Siddiqui A; Kowey PR
Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
[TBL] [Abstract][Full Text] [Related]
31. Stent and implantable cardioverter defibrillator implantation in medically resistant vasospastic angina patient.
Özyüncü N; Göksülük H; Vurgun VK; Yıldırım O; Tan Kürklü TS
Turk Kardiyol Dern Ars; 2017 Oct; 45(7):641-645. PubMed ID: 28990946
[TBL] [Abstract][Full Text] [Related]
32. Cigarette smoking and the risk of supraventricular and ventricular tachyarrhythmias in high-risk cardiac patients with implantable cardioverter defibrillators.
Goldenberg I; Moss AJ; McNitt S; Zareba W; Daubert JP; Hall WJ; Andrews ML;
J Cardiovasc Electrophysiol; 2006 Sep; 17(9):931-6. PubMed ID: 16759297
[TBL] [Abstract][Full Text] [Related]
33. Implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death.
Akhtar M; Jazayeri MR; Sra JS; Dhala A; Deshpande S; Blanck Z; Axtell K
Cardiol Clin; 1993 Feb; 11(1):97-108. PubMed ID: 8435827
[TBL] [Abstract][Full Text] [Related]
34. [Current management of patients with ventricular tachycardia].
Puljević D; Buljević B; Milicić D
Lijec Vjesn; 2001; 123(7-8):191-200. PubMed ID: 11729615
[TBL] [Abstract][Full Text] [Related]
35. Coronary vasospasm-induced ventricular tachyarrhythmias.
D'Agate DJ; Schwartz R; Lazar JM
J Invasive Cardiol; 2002 Oct; 14(10):609-14. PubMed ID: 12368515
[TBL] [Abstract][Full Text] [Related]
36. [Coronary spastic angina and it's associated diseases].
Nakayama M
Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():74-82. PubMed ID: 17952978
[No Abstract] [Full Text] [Related]
37. Importance of ventricular tachycardia storms not terminated by implantable cardioverter defibrillators shocks in patients with CASQ2 associated catecholaminergic polymorphic ventricular tachycardia.
Marai I; Khoury A; Suleiman M; Gepstein L; Blich M; Lorber A; Boulos M
Am J Cardiol; 2012 Jul; 110(1):72-6. PubMed ID: 22481011
[TBL] [Abstract][Full Text] [Related]
38. Coronary vasospasm-induced acute coronary syndrome complicated by life-threatening cardiac arrhythmias in patients without hemodynamically significant coronary artery disease.
Hung MJ; Cheng CW; Yang NI; Hung MY; Cherng WJ
Int J Cardiol; 2007 Apr; 117(1):37-44. PubMed ID: 16844245
[TBL] [Abstract][Full Text] [Related]
39. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
Noll G; Kaufmann U; Wenzel RR; Lüscher TF
Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
[TBL] [Abstract][Full Text] [Related]
40. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
